SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-18-000033
Filing Date
2018-01-02
Accepted
2018-01-02 16:06:29
Documents
5
Period of Report
2018-01-02

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT OF FOREIGN ISSUER f6k010218_biondvax.htm 6-K 12000
2 PRESS RELEASE DATED DECEMBER 27, 2017 f6k010218ex99-1_biondvax.htm EX-99.1 11067
3 PRESS RELEASE DATED JANUARY 2, 2018 f6k010218ex99-2_biondvax.htm EX-99.2 10203
4 GRAPHIC image_003.jpg GRAPHIC 811
5 GRAPHIC image_004.jpg GRAPHIC 9022
  Complete submission text file 0001213900-18-000033.txt   48086
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 18501825
SIC: 2836 Biological Products, (No Diagnostic Substances)